Burden of risk variants correlates with phenotype of multiple sclerosis

Abstract

Background:

More than 100 common variants underlying multiple sclerosis (MS) susceptibility have been identified, but their effect on disease phenotype is still largely unknown.

Objective:

The objective of this paper is to assess whether the cumulative genetic risk score of currently known susceptibility variants affects clinical presentation.

Methods:

A cumulative genetic risk score was based on four human leukocyte antigen (HLA) and 106 non-HLA risk loci genotyped or imputed in 842 Belgian MS patients and 321 controls. Non-parametric analyses were applied.

Results:

An increased genetic risk is observed for MS patients, including subsets such as oligoclonal band-negative and primary progressive MS patients, compared to controls. Within the patient group, a stronger association between HLA risk variants and the presence of oligoclonal bands, an increased immunoglobulin G (IgG) index and female gender was apparent. Results suggest an association between a higher accumulation of non-HLA risk variants and increased relapse rate as well as shorter relapse-free intervals after disease onset.

Conclusion:

MS patients display a significantly increased genetic risk compared to controls, irrespective of disease course or presence of oligoclonal bands. Whereas the cumulative burden of non-HLA risk variants appears to be reflected in the relapses of MS patients, the HLA region influences intrathecal IgG levels.

Keywords

Multiple sclerosis genetic risk genetic association disease course oligoclonal bands IgG index relapse rate

Get full access to this article

View all access options for this article.

References

Compston

Coles

. Multiple sclerosis. Lancet 2008; 372: 1502–1517.

International Multiple Sclerosis Genetics Consortium & Wellcome Trust Case Control Consortium 2. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011; 476: 214–219.

International Multiple Sclerosis Genetics Consortium. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 2013; 45: 1353–1360.

Sawcer

Franklin

Ban

. Multiple sclerosis genetics. Lancet Neurol 2014; 13: 700–709.

De Jager

Chibnik

Cui

. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: A weighted genetic risk score. Lancet Neurol 2009; 8: 1111–1119.

Sawcer

Ban

Wason

. What role for genetics in the prediction of multiple sclerosis? Ann Neurol 2010; 67: 3–10.

Gourraud

McElroy

Caillier

. Aggregation of multiple sclerosis genetic risk variants in multiple and single case families. Ann Neurol 2011; 69: 65–74.

Isobe

Damotte

Lo Re

. Genetic burden in multiple sclerosis families. Genes Immun 2013; 14: 434–440.

Harbo

Isobe

Berg-Hansen

. Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis. Mult Scler 2013; 20: 660–668.

10.

Sorosina

Brambilla

Clarelli

. Genetic burden of common variants in progressive and bout-onset multiple sclerosis. Mult Scler 2014; 20: 802–811.

11.

Disanto

Dobson

Pakpoor

. The refinement of genetic predictors of multiple sclerosis. PLoS One 2014; 9: e96578.

12.

Poser

Paty

Scheinberg

. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227–231.

13.

McDonald

Compston

Edan

. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121–127.

14.

Browning

. Simultaneous genotype calling and haplotype phasing improves genotype accuracy and reduces false-positive associations for genome-wide association studies. Am J Hum Genet 2009; 85: 847–861.

15.

Dilthey

Moutsianas

Leslie

. HLA*IMP—an integrated framework for imputing classical HLA alleles from SNP genotypes. Bioinformatics 2011; 27: 968–972.

16.

Sawcer

Wason

. Risk in complex genetics: “All models are wrong but some are useful”. Ann Neurol 2012; 72: 502–509.

17.

Hensiek

Sawcer

Feakes

. HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis. J Neurol Neurosurg Psychiatry 2002; 72: 184–187.

18.

Smestad

Brynedal

Jonasdottir

. The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients. Eur J Neurol 2007; 14: 835–840.

19.

Mero

Gustavsen

Saether

. Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles. PLoS One 2013; 8: e58352.

20.

Leone

Barizzone

Esposito

. Association of genetic markers with CSF oligoclonal bands in multiple sclerosis patients. PLoS One 2013; 8: e64408.

21.

Ebers

. Natural history of primary progressive multiple sclerosis. Mult Scler 2004; 10 (Suppl 1): S8–S13; discussion S13–S15.

22.

Hensiek

Seaman

Barcellos

. Familial effects on the clinical course of multiple sclerosis. Neurology 2007; 68: 376–383.

23.

Buck

Albrecht

Aslam

. Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis. Ann Neurol 2013; 73: 86–94.

24.

Lin

Taylor

Simpson

Jr . Association between multiple sclerosis risk-associated SNPs and relapse and disability—a prospective cohort study. Mult Scler 2014; 20: 313–321.

25.

Mowry

Carey

Blasco

. Multiple sclerosis susceptibility genes: Associations with relapse severity and recovery. PLoS One 2013; 8: e75416.

26.

Balnyte

Rastenyte

Vaitkus

. The importance of HLA DRB1 gene allele to clinical features and disability in patients with multiple sclerosis in Lithuania. BMC Neurol 2013; 13: 77.

27.

Held

Heigenhauser

Shang

. Predictors of relapse rate in MS clinical trials. Neurology 2005; 65: 1769–1773.

28.

Tremlett

Zhao

Joseph

. Relapses in multiple sclerosis are age- and time-dependent. J Neurol Neurosurg Psychiatry 2008; 79: 1368–1374.

29.

Young

Lederer

Eder

. Relapses and subsequent worsening of disability in relapsing–remitting multiple sclerosis. Neurology 2006; 67: 804–808.

30.

Van der

Walt A

Stankovich

Bahlo

. Heterogeneity at the HLA-DRB1 allelic variation locus does not influence multiple sclerosis disease severity, brain atrophy or cognition. Mult Scler 2011; 17: 344–352.

31.

van Pelt

Mescheriakova

Makhani

. Risk genes associated with pediatric-onset MS but not with monophasic acquired CNS demyelination. Neurology 2013; 81: 1996–2001.

32.

Roxburgh

RHSR

Seaman

Masterman

. Multiple sclerosis severity score: Using disability and disease duration to rate disease severity. Neurology 2005; 64: 1144–1151.

33.

Kantarci

Barcellos

Atkinson

. Men transmit MS more often to their children vs women: The Carter effect. Neurology 2006; 67: 305–310.

34.

Sawcer

. The complex genetics of multiple sclerosis: Pitfalls and prospects. Brain 2008; 131: 3118–3131.

35.

Herrera

Ramagopalan

Orton

. Parental transmission of MS in a population-based Canadian cohort. Neurology 2007; 69: 1208–1212.

36.

Sadovnick

AD.

Differential effects of genetic susceptibility factors in males and females with multiple sclerosis. Clin Immunol 2013; 149: 170–175.

37.

Chao

Ramagopalan

Herrera

. MHC transmission: Insights into gender bias in MS susceptibility. Neurology 2011; 76: 242–246.

38.

Irizar

Muñoz-Culla

Zuriarrain

. HLA-DRB1*15:01 and multiple sclerosis: A female association? Mult Scler 2012; 18: 569–577.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.13 MB